Steve Byrne analyst BAML

Currently out of the existing stock ratings of Steve Byrne, 124 are a HOLD (29.31%), 89 are a SELL (21.04%), 210 are a BUY (49.65%).

Steve Byrne

Work Performance Price Targets & Ratings Chart

Analyst Steve Byrne, currently employed at BAML, has had 61.64% of price targets met with an average potential upside of 24.89%, reached in 305 days on average.

Steve Byrne has documented 815 price targets and ratings displayed on 46 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare, Technology sectors.

Most recent stock forecast was given on OLN, Olin at 30-Jun-2026.

Wall Street Analyst Steve Byrne

Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) on 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%), with a performance score of 41.67.

Average potential price target upside

ALB Albemarle Corp CE Celanese CF CF Industries Holdings CTVA Corteva DD Dupont De Nemours FMC FMC HUN Huntsman LIN Linde plc LTHM Livent Corp LYB LyondellBasell Industries NV MOS The Mosaic Company NTR Nutrien Ltd OLN Olin RPM RPM International SHW Sherwin-Williams Co WLK Westlake Chemical APD Air Products and Chemicals BG Bunge ECL Ecolab PPG PPG Industries UNVR Univar VNTR Venator Materials PLC ADM Archer-Daniels-Midland Company AXTA Axalta Coating Systems Ltd GPRE Green Plains Renewable Energy ORGN Origin Materials DOW Dow MNKD MannKind Corp PCRX Pacira Pharmaceuticals SRPT Sarepta Therapeutics EMN Eastman Chemical Company CC Chemours Co ESI Element Solutions WLKP Westlake Chemical Partners LP INVA Innoviva OREX Orexigen Therapeutics PE Parsley Energy ALKS Alkermes Plc ARNA Arena Pharmaceuticals DSEY Diversey Holdings Ltd MGNX MacroGenics RPRX Royalty Pharma Plc SGEN Seagen SGML Sigma Lithium Resources Corp TROX Tronox Holdings PLC VNT Vontier Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Feb-2022

$119

$25.47 (27.23%)

$129

8 days ago
(09-Nov-2026)

37/52 (71.15%)

$20.63 (20.97%)

490

Buy Since 15-May-2026

$165

$71.47 (76.41%)

$190

8 days ago
(09-Nov-2026)

9/15 (60%)

$66.63 (67.73%)

397

Buy Since 22-Oct-2026

$140

$46.47 (49.68%)

$125

8 days ago
(09-Nov-2026)

7/15 (46.67%)

$41.63 (42.32%)

318

Hold Since 14-Apr-2026

$105

$11.47 (12.26%)

$189

8 days ago
(09-Nov-2026)

15/16 (93.75%)

$6.63 (6.74%)

287

Buy Since 06-Mar-2026

$170

$76.47 (81.76%)

$185

8 days ago
(09-Nov-2026)

10/18 (55.56%)

$71.63 (72.82%)

151

Show more analysts

Please expand the browser size to see the chart

Which stock is Steve Byrne most bullish on?

Potential upside of $3.54 has been obtained for OLN (OLIN)

What Year was the first public recommendation made by Steve Byrne?

On 2008
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?